论文部分内容阅读
氟罗沙星(Fleroxacin AM-833)是日本杏林公司开发的新喹诺酮类抗菌药,目前已首先在瑞士批准上市,商品名Quinodis,由瑞士Roche公司生产,有片剂(200mg/片或400mg/片)和注射剂(400mg/支)供应,适用于有并发症和无并发症的尿道感染、慢
Fleroxacin (Fleroxacin AM-833) is a new quinolone antibacterial drug developed by Japan’s Xinglin Company. It has been first approved in Switzerland under the trade name Quinodis and is manufactured by Roche Company in Switzerland with tablets (200mg / tablet or 400mg / tablet) And injection (400mg / support) supply, suitable for complications and complications of urinary tract infections, slow